- Papers in database
- 4
- Years active
- 2016 – 2021
- Health outcomes studied
- 1
Health Outcomes Studied
Papers (4)
- 2021An Exopolysaccharide Produced by Bifidobacterium longum 35624® Inhibits Osteoclast Formation via a TLR2-Dependent Mechanism10.1007/s00223-020-00790-4
- 2018Exopolysaccharide from Bifidobacterium longum subsp. longum 35624™ modulates murine allergic airway responses.10.3920/BM2017.0180
- 2016Genome Analysis and Characterisation of the Exopolysaccharide Produced by Bifidobacterium longum subsp. longum 35624™10.1371/journal.pone.0162983
- 2016The Surface-Associated Exopolysaccharide of Bifidobacterium longum 35624 Plays an Essential Role in Dampening Host Proinflammatory Responses and Repressing Local TH17 Responses10.1128/AEM.02238-16